Cargando…

T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?

Allogenic hematopoietic stem cell transplantation (allo-HSCT) represents a potent and potentially curative treatment for many hematopoietic malignancies and hematologic disorders in adults and children. The donor-derived immunity, elicited by the stem cell transplant, can prevent disease relapse but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campe, Julia, Ullrich, Evelyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766661/ https://www.ncbi.nlm.nih.gov/pubmed/35069590 http://dx.doi.org/10.3389/fimmu.2021.806529

Ejemplares similares

Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD)
por: Ullrich, Evelyn, et al.
Publicado: (2022)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Transcriptional and epigenetic regulation of T-helper lineage specification
por: Tripathi, Subhash K, et al.
Publicado: (2014)

Differential regulation of lineage-determining transcription factor expression in innate lymphoid cell and adaptive T helper cell subsets
por: Fang, Difeng, et al.
Publicado: (2023)

Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
por: Harris, Rebecca, et al.
Publicado: (2023)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation
por: Ullrich, Evelyn, et al.
Publicado: (2016)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

Milestones in acute GVHD pathophysiology
por: Socie, Gerard, et al.
Publicado: (2022)

Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA
por: Hid Cadena, Rebeca, et al.
Publicado: (2019)

Impact of oral microbiota on pathophysiology of GVHD
por: Yamamoto, Akira, et al.
Publicado: (2023)

Targeting Cytokines in GVHD Therapy
por: Kumar, Sandeep, et al.
Publicado: (2017)

Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2018)

Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis
por: Yarkoni, Shai, et al.
Publicado: (2014)

Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies
por: Naserian, Sina, et al.
Publicado: (2020)

The Transcription Factor c-Maf Promotes the Differentiation of Follicular Helper T Cells
por: Andris, Fabienne, et al.
Publicado: (2017)

CXCR5, the Defining Marker for Follicular B Helper T (T(FH)) Cells
por: Moser, Bernhard
Publicado: (2015)

Deep characterization of human γδ T cell subsets defines shared and lineage-specific traits
por: Sanz, Marta, et al.
Publicado: (2023)

Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022)

ER stress: an emerging regulator in GVHD development
por: Choi, Hee-Jin, et al.
Publicado: (2023)

Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis
por: Buchele, Vera, et al.
Publicado: (2018)

T Follicular Helper Cells As a New Target for Immunosuppressive Therapies
por: Yan, Lin, et al.
Publicado: (2017)

Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections
por: Huenecke, Sabine, et al.
Publicado: (2017)

The Interplay Between Chromatin Architecture and Lineage-Specific Transcription Factors and the Regulation of Rag Gene Expression
por: Miyazaki, Kazuko, et al.
Publicado: (2021)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
por: Ara, Takahide, et al.
Publicado: (2021)

Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
por: Mammadli, Mahinbanu, et al.
Publicado: (2020)

The transcription factor ThPOK acts late in helper T cell lineage specification and suppresses Runx-mediated commitment to the cytotoxic T cell lineage
por: Egawa, Takeshi, et al.
Publicado: (2008)

Pathophysiology of GvHD and Other HSCT-Related Major Complications
por: Ghimire, Sakhila, et al.
Publicado: (2017)

Controversies and expectations for the prevention of GVHD: A biological and clinical perspective
por: Watkins, Benjamin, et al.
Publicado: (2022)

Lineage origin and transcriptional control of autoantigen-specific T-regulatory type 1 cells
por: Angelats, Edgar, et al.
Publicado: (2023)

CCR9 Expressing T Helper and T Follicular Helper Cells Exhibit Site-Specific Identities During Inflammatory Disease
por: Cosorich, Ilaria, et al.
Publicado: (2019)

Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment
por: Hess, Nicholas J., et al.
Publicado: (2023)

Identification of global regulators of T-helper cell lineage specification
por: Kanduri, Kartiek, et al.
Publicado: (2015)

Transcriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages
por: Friedman, Meyer J., et al.
Publicado: (2023)

The Pioneer Transcription Factor Foxa2 Modulates T Helper Differentiation to Reduce Mouse Allergic Airway Disease
por: Yánez, Diana C., et al.
Publicado: (2022)

Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases
por: Capone, Alessia, et al.
Publicado: (2020)

Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2023)

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)

The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations
por: Zhao, Chenchen, et al.
Publicado: (2021)

GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models
por: Hess, Nicholas J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5vf2uc1is02cf8rvcb0glkucjg